Search

In this work, the possibility of fabricating composite magneto-optical ceramics by electrophoretic deposition (EPD) of nanopowders and high-temperature vacuum sintering of the compacts was investigated. Holmium oxide was chosen as a magneto-optical material for the study because of its transparency in the mid-IR range. Nanopowders of magneto-optical (Ho0.95La0.05)2O3 (HoLa) material were made by self-propagating high-temperature synthesis. Nanopowders of (Y0.9La0.1)2O3 (YLa) were made by laser synthesis for an inactive matrix. The process of formation of one- and two-layer compacts by EPD of the nanopowders from alcohol suspensions was studied in detail. Acetylacetone was shown to be a good dispersant to obtain alcohol suspensions of the nanopowders, characterized by high zeta potential values (+29–+80 mV), and to carry out a stable EPD process. One-layer compacts were made from the HoLa and YLa nanopowders with a density of 30–43%. It was found out that the introduction of polyvinyl butyral (PVB) into the suspension leads to a decrease in the mass and thickness of the green bodies deposited, but does not significantly affect their density. The possibility of making two-layer (YLa/HoLa) compacts with a thickness of up to 2.6 mm and a density of up to 46% was demonstrated. Sintering such compacts in a vacuum at a temperature of 1750 °C for 10 h leads to the formation of ceramics with a homogeneous boundary between the YLa/HoLa layers and a thickness of the interdiffused ion layer of about 30 μm.

In recent years, paramagnetic nanoparticles (NPs) have been widely used for magnetic resonance imaging (MRI). This paper reports the fabrication and toxicity evaluation of polyethylene glycol (PEG)-functionalized holmium oxide (Ho2O3) NPs for potential T2-weighted MRI applications. Various characterization techniques were used to examine the morphology, structure and chemical properties of the prepared PEG–Ho2O3 NPs. MRI relaxivity measurements revealed that PEG–Ho2O3 NPs could generate a strong negative contrast in T2-weighted MRI. The pilot cytotoxicity experiments showed that the prepared PEG–Ho2O3 NPs are biocompatible at concentrations less than 16 μg/mL. Overall, the prepared PEG–Ho2O3 NPs have potential applications for T2-weighted MRI imaging.